Predicting brain injury in newborns with jaundice
Part of Genetic & congenital clinical trials.
This trial studies if a blood test measuring the ratio of two proteins can better predict brain damage from severe jaundice than the current standard test. It aims to help doctors identify babies who need faster treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newborn babies aged 1 to 28 days old
- Has jaundice severe enough to need phototherapy or a blood exchange transfusion
- Full-term or premature babies are welcome
- Both boys and girls can join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a new device can accurately detect and track yellowing of the skin (newborn jaundice) in hospitals with limited resources. It may help clinicians monitor jaundice and decide on treatments like blue light therapy more reliably.
This trial tests a scoring tool called BIND to see how well it predicts which newborns with severe jaundice need intensive treatment. If you have a baby under 28 days old with severe jaundice that might need a blood transfusion, this study could apply to them.
This trial compares different blood-bilirubin (jaundice) thresholds for treating very premature babies (born before 30 weeks) in the NICU. It aims to find the safest way to manage jaundice to prevent complications.
This study tests a new method to measure how much fetal blood leaks into the mother's bloodstream, which can cause severe jaundice in newborns. It may help doctors diagnose hemolytic disease of the newborn earlier and more accurately.
This trial uses a special breath test (ETCOc) to measure jaundice in newborns, aiming to improve diagnosis and treatment. It may help doctors decide when treatment is needed.
This trial tests whether giving probiotics (healthy bacteria) to newborns with jaundice helps them get better faster when they are also receiving light therapy (phototherapy). It is for babies with moderate jaundice who need treatment and do not have other serious health issues.
Hear when a new Hyperbilirubinemia, Neonatal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.